Usefulness of N-terminal pro-B-type natriuretic peptide in patients admitted to the intensive care unit: A multicenter prospective observational study

Chin K. Rhee, So Y. Lim, Shin O. Koh, Won Il Choi, Young Joo Lee, Gyu R. Chon, Je Hyeong Kim, Jae Y. Kim, Jaemin Lim, Sunghoon Park, Ho C. Kim, Jin H. Lee, Ji H. Lee, Jisook Park, Younsuck Koh, Gee Y. Suh, Seok C. Kim, Kyeongman Jeon, Chi Min Park, Chae Man LimSang Bum Hong, Jin Won Huh, Suk Kyung Hong, Sungwon Na, Kwang Joo Park, Chan Kwon Park, Jae Hwa Cho

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: The role of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) as a prognostic factor in patients admitted to the intensive care unit (ICU) is not yet fully established. We aimed to determine whether NT-pro-BNP is predictive of ICU mortality in a multicenter cohort of critically ill patients. Methods: A total of 1440 patients admitted to 22 ICUs (medical, 14; surgical, six; multidisciplinary, two) in 15 tertiary or university-affiliated hospitals between July 2010 and January 2011 were assessed. Patient data, including NT-pro-BNP levels and Simplified Acute Physiology Score (SAPS) 3 scores, were recorded prospectively in a web-based database. Results: The median age was 64 years (range, 53-73 years), and 906 (62.9%) patients were male. The median NT-pro-BNP level was 341 pg/mL (104-1,637 pg/mL), and the median SAPS 3 score was 57 (range, 47-69). The ICU mortality rate was 18.9%, and hospital mortality was 24.5%. Hospital survivors showed significantly lower NT-pro-BNP values than nonsurvivors (245 pg/mL [range, 82-1,053 pg/mL] vs. 875 pg/mL [241-5,000 pg/mL], respectively; p < 0.001). In prediction of hospital mortality, the area under the curve (AUC) for NT-pro-BNP was 0.67 (95% confidence interval [CI], 0.64-0.70) and SAPS 3 score was 0.83 (95% CI, 0.81-0.85). AUC increment by adding NT-pro-BNP is minimal and likely no different to SAPS 3 alone. Conclusions: The NT-pro-BNP level was more elevated in nonsurvivors in a multicenter cohort of critically ill patients. However, there was little additional prognostic power when adding NT-pro-BNP to SAPS 3 score.

Original languageEnglish
Article number16
JournalBMC Anesthesiology
Volume14
DOIs
Publication statusPublished - 2014 Mar 10

Keywords

  • Critical care
  • Intensive care unit
  • N-terminal pro-B-type natriuretic peptide
  • Prognosis

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Usefulness of N-terminal pro-B-type natriuretic peptide in patients admitted to the intensive care unit: A multicenter prospective observational study'. Together they form a unique fingerprint.

  • Cite this

    Rhee, C. K., Lim, S. Y., Koh, S. O., Choi, W. I., Lee, Y. J., Chon, G. R., Kim, J. H., Kim, J. Y., Lim, J., Park, S., Kim, H. C., Lee, J. H., Lee, J. H., Park, J., Koh, Y., Suh, G. Y., Kim, S. C., Jeon, K., Park, C. M., ... Cho, J. H. (2014). Usefulness of N-terminal pro-B-type natriuretic peptide in patients admitted to the intensive care unit: A multicenter prospective observational study. BMC Anesthesiology, 14, [16]. https://doi.org/10.1186/1471-2253-14-16